Obstetrics & Gynecology Doctors in Avon, CT Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Maura Graham, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20 W Avon Rd Ste 201, Avon, CT 06001 Phone: 860-673-4670

Brigitte Worgaftik, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 20 W Avon Rd, Avon, CT 06001 Phone: 860-673-4670    Fax: 860-673-4584

Jodi Leopold, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 20 W Avon Rd, Avon, CT 06001 Phone: 860-673-4670    Fax: 860-675-3422

Matthew Saidel, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 20 West Avon Rd, Avon, CT 06001 Phone: 860-673-4670    Fax: 860-673-4584

Odin Kuiper, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20 West Avon Rd, Avon, CT 06001 Phone: 860-673-4670    Fax: 860-675-3422

Mary E Farwell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 20 West Avon Rd, Avon, CT 06001 Phone: 860-673-4670    Fax: 860-675-3422

News Archive

CFDA accepts WuXi MedImmune's novel anti-IL6 monoclonal antibody IND application for review

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration.

Brain has more than one pathway along which visual information can be sent

Visual information can be processed unconsciously when the area of the brain that records what the eye sees is temporarily shut down, according to research at Rice University in Houston.

PsiOxus Therapeutics presents positive study results of anti-cancer vaccine Enadenotucirev at ASCO Annual Meeting

PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

Emdeon and BroMenn Healthcare System implement an interactive software application for transparent pricing of healthcare

Emdeon, a leading provider of revenue and payment cycle management solutions for the healthcare industry, and BroMenn Healthcare System, headquartered in Bloomington-Normal, Illinois, recently implemented the Emdeon Patient Responsibility Estimator(SM) solution. Emdeon Patient Responsibility Estimator is an interactive software application used by BroMenn's patient access staff to inform patients of their financial responsibility prior to care delivery.

Read more Medical News

› Verified 8 days ago